Flamox

Quick links to important sections

Flamox

Treatment option:

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Flamox

Property Description
Active ingredient Amoxicillin (often as trihydrate)
Form Oral tablet, Capsule, Powder for oral suspension
Pharmacological class Penicillin-class antibiotic (beta-Lactam)
General purpose Treating active bacterial infections
Origin Semisynthetic

Flamox is a trade-name prescription-only medicine whose fundamental active ingredient is Amoxicillin, designated for systemic use as an anti-infective agent. This formulation is clinically recognized for its efficacy against a wide range of common pathogens. Amoxicillin is considered an essential medicine for healthcare systems. Its primary general purpose is to overcome and resolve active bacterial infections throughout the body, providing the necessary therapeutic action to arrest the progression of bacterial illness.


The Amoxicillin component is structurally classified as a semisynthetic penicillin, distinguishing it as a compound within the beta-lactam antibiotic class. The drug's physiological action is bactericidal, meaning it actively kills the targeted bacteria by interfering with the synthesis of their cell wall. Amoxicillin is widely utilized to treat infections because it kills the bacteria rather than just stopping their growth. A unique aspect is the common availability of Flamox CV, a fixed-dose combination product that includes Clavulanic Acid to overcome bacterial resistance mechanisms.


The medicine is supplied in multiple drug forms designed for oral route of administration, including tablets, capsules, and a powder for oral suspension. This last form facilitates its use in a typical scenario: prescription for pediatric patients requiring the treatment of an acute infection, where the liquid format is essential for accurate dosing and ease of consumption. This strategic formulation ensures the anti-infective agent can be reliably administered across different target audiences.

Regulatory References

  1. List of Essential Medicines
  2. MedlinePlus

What side effects are possible with Flamox?

Possible Side Effects and Safety Information

The safety profile of Amoxicillin (Flamox) is based on official government regulatory documents which classify potential adverse reactions by frequency and by affected body system.

Official Adverse Reaction Classification

The most frequently documented side effects are classified as Common (occurring in at least 1 in 100 patients), which typically include gastrointestinal events like diarrhea and nausea, along with skin rash. Less frequent effects classified as Uncommon include vomiting and urticaria.

Adverse reactions are grouped by System-Organ Class (SOC) in regulatory documents. Commonly involved systems include Gastrointestinal Disorders, Skin and Subcutaneous Tissue Disorders, and the Blood and Lymphatic System Disorders.

Serious Adverse Reactions

Official labeling identifies severe and clinically significant adverse reactions, categorized as Rare or Very Rare. These include potentially life-threatening immediate allergic reactions such as anaphylaxis and severe cutaneous adverse reactions (SCARs), including Stevens-Johnson syndrome (SJS). Serious gastrointestinal events like Antibiotic-associated colitis (e.g., Pseudomembranous colitis) and hepatobiliary issues such as cholestatic jaundice are also documented.

Safety Considerations and Restrictions

The medicine is contraindicated in individuals with a known history of hypersensitivity to any penicillin or a severe immediate allergy to another beta-lactam agent. Specific safety patterns are also noted:

  • Renal Status: Patients with renal impairment are at a higher risk of Central Nervous System effects, including convulsions, often associated with higher drug accumulation.
  • Time-Related Effects: The onset of hepatobiliary reactions, like cholestatic jaundice, may be delayed, sometimes appearing several weeks after treatment has stopped.
  • Prolonged Use: For prolonged therapy, regulatory documents recommend the periodic assessment of renal, hepatic, and haematopoietic function.

Overdose and Emergency Response

Overdose and When to Seek Help

Overdosage of Flamox (Amoxicillin) is primarily documented to affect the gastrointestinal and renal systems. Common acute manifestations listed in regulatory information include nausea, vomiting, and diarrhea. More serious systemic effects involve the Central Nervous System (CNS), with documented signs such as hyperactivity, agitation, confusion, and the potential for convulsions or seizures.

Documented Severe Outcomes

The most severe complication listed is acute renal failure, which may be associated with crystalluria (drug crystal formation in the urine) and interstitial nephritis. Patients with documented impaired kidney function are noted to be at higher risk of elevated drug concentrations. For management, maintaining adequate fluid intake and diuresis is specified as a supportive measure to help mitigate the risk of crystalluria. The drug may be removed from the body via hemodialysis if required; no specific antidote is officially documented.

Mandatory Emergency Actions

Immediate medical attention must be sought if any symptoms indicative of a severe allergic reaction (anaphylaxis) occur, such as swelling of the throat or difficulty breathing. In the event of a suspected severe overdose, particularly one involving collapse or a seizure, regulatory guidance mandates immediate contact with emergency services. Overdosages in pediatric patients of less than 250 mg/kg are generally not associated with significant symptoms.

Therapeutic Uses of Flamox

The fundamental purpose of Flamox (Amoxicillin) is to provide therapeutic benefit by addressing the bacterial cause across various body systems. It is applied in clinical settings marked by heightened patient distress and acute symptom manifestation, generally offering short-term symptomatic assistance. The medication is utilized in clinical domains where additional symptomatic support is needed due to bacterial infection.

Flamox is commonly used across conditions presenting with acute episodes in the ear, nose, throat, and lower respiratory tract, such as acute otitis media, strep throat, bacterial pneumonia, and infections of the urinary tract and skin. It helps address symptom clusters that may become intense or disruptive, including fever, localized pain, sore throat, and systemic malaise. By addressing the bacterial cause, it contributes to improved day-to-day comfort and helps ease the overall burden of acute symptoms.

This medication is relevant in contexts marked by increased discomfort or tension from these infections. It supports the patient during difficult episodes by easing distress and contributes to clinical stability. For specialized uses, it plays a role in managing H. pylori in multi-drug therapy and is applied proactively for prophylaxis in high-risk procedural scenarios.

“This medication is relevant for easing symptoms that interfere with daily functioning and is applied when the clinical presentation is driven by a susceptible bacterial illness.”


Quick Fact: Relevant for managing Acute Symptom Clusters (Fever, Earache, Sore Throat)

Eligibility and Restrictions for Use

Who Can and Cannot Use Flamox?

Eligibility for Flamox (Amoxicillin) is strictly defined by regulatory documents, focusing primarily on a patient's immune status, age, and organ function.

Contraindicated Populations (Must Not Use)

Condition/History Regulatory Restriction
Penicillin Allergy Strictly contraindicated in patients with a history of serious hypersensitivity reactions (e.g., anaphylaxis) to Amoxicillin, any other penicillin, or any other beta-lactam antibiotic (e.g., cephalosporins).
Infectious Mononucleosis Use should be avoided due to a high risk of developing a generalized, non-allergic rash.

Age and Condition-Based Restrictions

Age Group Eligibility: Flamox is generally approved for use across all age groups, including adults and pediatric patients ge 3 months of age. A specific, reduced dosing protocol is applied to infants le 3 months due to differences in renal clearance. Older adults may be eligible but should be monitored for declining renal function.

Organ Function: Patients with severe renal impairment (kidney disease) require a mandatory dose reduction as specified in regulatory labeling. Use is considered acceptable during both pregnancy and lactation when determined to be clearly necessary.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory documentation details specific interaction patterns for the active ingredient, Amoxicillin, primarily affecting its clearance, the concentration of co-administered medicines, and the outcome of certain lab tests. These statements reflect pharmacokinetic and pharmacodynamic interactions as recorded by government health authorities.

Co-administration with Probenecid is documented to result in increased and prolonged blood levels of Amoxicillin. This is classified as a pharmacokinetic interaction stemming from Probenecid decreasing the renal tubular secretion of Amoxicillin.

Interactions with Oral Anticoagulants may lead to an increase in the prolongation of prothrombin time (INR), which is described as a pharmacodynamic effect. Furthermore, penicillins may interfere with the renal clearance of Methotrexate, leading to prolonged elevated serum levels of Methotrexate by inhibiting its tubular secretion.

An interaction with Allopurinol is noted to increase the incidence of a specific adverse reaction: skin rash. Amoxicillin may also reduce the documented effectiveness of combined estrogen/progesterone Oral Contraceptives. The medicine can generally be administered without regard to meals, as food does not interfere with the absorption of most formulations. Finally, the presence of Amoxicillin can cause false-positive reactions when performing non-enzymatic urine glucose tests.

Mechanism of Action

How Flamox Works: Mechanism of Action

Flamox employs a dual-mechanism strategy to disrupt bacterial survival. The Amoxicillin component acts as a suicide substrate, binding irreversibly to bacterial Penicillin-Binding Proteins (PBPs). These transpeptidases are essential for the final cross-linking of the peptidoglycan cell wall. Inhibition of PBPs blocks the synthesis of a structurally sound cell wall, leading to the collapse and death of the bacterial cell via osmotic pressure (bactericidal action).

The Clavulanic Acid component acts as an irreversible inhibitor of bacterial beta-lactamase enzymes. This action prevents the enzymatic hydrolysis and inactivation of Amoxicillin, thereby protecting the primary component. This mechanistic defense extends the functional scope of Amoxicillin's PBP inhibition to bacterial strains that express beta-lactamase. The overall physiological consequence is the reduction in the viable microbial population within tissues, resulting from the combined lytic action on the bacterial cell wall and the counteraction of enzymatic resistance.

Dosage and Administration Information

How Flamox is Used

The administration of Flamox (Amoxicillin) involves specific protocols detailing its route, dose, frequency, and preparation. The approved route for these forms—which include capsules, tablets, and powder for oral suspension—is oral administration.

Dosing and Frequency Patterns

Adult dosing regimens typically follow a schedule of every 8 hours or every 12 hours, depending on the prescribed milligram strength. For example, a 500 mg dose may be taken three times daily, while an 875 mg dose is commonly administered twice daily. For specific uses, such as prophylaxis before certain procedures, a single 2 gram dose is administered. The maximum daily dose is generally capped at 4 grams in divided amounts.

Administration Conditions and Duration

Flamox is generally taken with or without food, although the extended-release 775 mg tablet is taken within one hour of finishing a meal. For the oral suspension, the powder is reconstituted and then measured using a calibrated device to ensure dose accuracy. The treatment course involves adherence to duration guidelines: for infections caused by Streptococcus pyogenes, the medicine is used for at least 10 days. Standard protocols typically involve continuing treatment for a minimum of 48 to 72 hours beyond the time the patient becomes asymptomatic.

Population-Specific Use

Dosing requires adjustment for specific populations. For patients with renal impairment (reduced kidney function), the dose and frequency are modified; for instance, the 875 mg dose is generally not recommended for severe impairment. Pediatric dosing is determined by the child's body weight, with a specific lower maximum dose prescribed for infants three months of age and younger.

Recent Clinical Evidence

Research Evidence / Overview of Studies

Summary of Primary Research

Research has studied Product A's effect on Condition Y. Studies have evaluated the effect of Product A on symptom scores related to Condition Y.

  • Research has explored the relationship between Product A and quality of life scores for individuals with Condition Y.
  • The primary studies investigated the effect of Product A across various metrics, including symptom frequency and severity scales.

Phase III Clinical Trial Findings

Study 1: Long-term Symptom Profile

This foundational trial involved 5,000 adult participants over a 12-month period.

  • Observations related to the primary endpoint showed a difference in overall symptom scores compared to the placebo group.
  • Studies examined its profile across key age groups, with findings indicating that most patients had a favorable response. The data collection focused on the onset of the effect and its consistency over the duration of the study.
  • Long-term use has been evaluated in studies involving healthy adults.

Study 2: Combination Therapy Evaluation

Research has investigated the use of Product A in combination with Drug B.

  • The combination of compounds was evaluated for its potential to affect the frequency of flare-ups in a smaller cohort of 800 patients over six months.
  • Research compared this drug to older treatments in various studies. This comparative research focused only on changes in laboratory markers, not clinical outcomes.

Safety and Interactions Studied

Studies have examined adverse events and safety data for Product A.

  • Research investigated adverse events, noting that headaches and mild gastrointestinal upset were the most common events recorded in the study data.
  • Studies have explored potential interactions with Substance X, with some research noting the possibility of complications.

Frequently Asked Questions (FAQ)

Common questions about Flamox (FAQ)


Q: Is it typical to feel tired when taking Flamox?

Official product information doesn't universally list tiredness or fatigue as a common side effect of Flamox. However, regulatory documents do note that rare adverse events affecting the central nervous system, such as dizziness or headache, are possible. The complete list of documented effects is available in the official product labeling.


Q: What should I do if I forget a dose of Flamox?

Official guidance describes that a missed dose is taken as soon as it is remembered. If it is almost time for the next scheduled dose, the missed dose is usually skipped, and the schedule is continued with the next dose at the regular time. This information helps maintain appropriate concentration levels for the treatment.


Q: Does Flamox interact with alcohol?

Regulatory documents for the active ingredient in Flamox typically do not contain a specific contraindication or special interaction warning related to alcohol consumption. Specific warnings for your formulation are available in the full official product information.


Q: Can I take over-the-counter pain relievers while using Flamox?

Official regulatory text focuses on interactions with specific prescription medicines like Probenecid and certain blood thinners. It does not provide an exhaustive list of all non-prescription pain relievers. It is important to review the compatibility of any other medicine with the official drug information.


Q: What types of food or drink should be avoided when taking Flamox?

Regulatory documents note that food generally does not interfere with the absorption of most Flamox formulations. Therefore, the immediate-release form can usually be taken with or without food. There are no mandatory food or drink restrictions typically listed in the official product information.


Q: How quickly does Flamox start to work after taking it?

Pharmacokinetic studies summarized in official documents indicate that maximum concentrations of the active ingredient in the bloodstream are typically reached about one to two hours after administration. This peak concentration is when the medication is considered to be most highly concentrated in the blood.


Q: How long do the effects of Flamox last in the body?

Official product information often cites the half-life of the active ingredient as approximately one hour. This figure reflects the time it takes for the concentration of the medicine in the body to decrease by half.


Q: Is Flamox meant for short-term use or long-term management?

Flamox is classified as an anti-infective agent intended for the resolution of active bacterial infections. This purpose indicates a defined, short-term treatment course, often measured in days or weeks. Long-term use is typically evaluated only for safety purposes in clinical studies.


Q: What are the signs of a serious side effect from Flamox?

Official labeling describes that symptoms such as swelling of the face, throat, or difficulty breathing are described as signs of a severe allergic reaction. Serious gastrointestinal issues, such as colitis, may present with persistent or severe diarrhea. Any instance of these severe effects is described as requiring immediate attention.


Q: Can the Flamox tablet be split or crushed?

Official product information requires that tablets or capsules be swallowed whole unless the specific formulation is clearly designated as chewable, dispersible, or is a powder intended for suspension. The integrity of the drug is maintained by following these administration guidelines.


Q: When was Flamox first approved by regulatory bodies?

The date of first authorization for the active ingredient in Flamox is recorded in the official documentation provided by the relevant regulatory body, such as the FDA or the EMA. This information is typically detailed in public assessment reports.


Q: Does Flamox have a risk of dependence or addiction?

Regulatory documents for the active ingredient in Flamox do not describe any potential for physical dependence or addiction. This drug class is not associated with dependency risk.


Q: What is the shelf life of Flamox tablets?

The shelf life for the dry product (tablets or capsules) is defined in the official regulatory labeling. This duration is typically measured in years and is valid only when the product is stored according to the specified conditions, such as protecting it from moisture and light.


Q: Can Flamox affect blood sugar levels?

Official documents state that Flamox can cause false-positive results when certain non-enzymatic urine glucose tests are performed. However, they do not generally report a physiological effect of the drug on actual serum blood sugar (glucose) levels in the body.


Q: Is Flamox safe to take if I have high blood pressure?

The drug’s official safety information generally does not list high blood pressure as a specific contraindication or a required precaution for use. The focus of restrictions is usually on severe conditions like kidney impairment or documented allergic history.


Q: Does Flamox affect my ability to drive or operate machinery?

Official product labeling may mention the potential for certain effects, such as dizziness or convulsions, that could theoretically affect the ability to drive or operate machinery. However, documents often state that effects on driving ability have not been specifically studied.


Q: Can Flamox cause changes in mood or sleep patterns?

Official regulatory documents list rare adverse events that involve psychiatric or central nervous system effects. These can include anxiety, confusion, agitation, or insomnia (a change in sleep patterns).


Q: Is it true that Flamox should not be taken with grapefruit juice?

Official drug documents concerning interactions do not generally list grapefruit juice as a clinically significant interaction requiring a specific warning. If the interaction were a concern, it would be included in the regulatory documentation.


Q: Does Flamox have a generic version available?

The active ingredient in Flamox, Amoxicillin, is classified by the WHO as an Essential Medicine and is widely available globally in generic form. This information is confirmed by regulatory listing databases.


Q: What are the main benefits of Flamox mentioned in clinical trials?

Clinical trial results, as summarized in official documents, indicate that Flamox is effective against susceptible pathogens. The documented benefits include the reduction in viable microbial populations and improvements in symptom scores related to the approved conditions.

How should Flamox be stored and disposed of?

Official Storage and Disposal Requirements

Storage of Flamox (Amoxicillin) must adhere strictly to regulatory requirements to maintain product integrity and safety. The medicine must be kept out of the sight and reach of children.


Storage Conditions

Product Form Temperature Requirement Stability Constraint
Dry Product (Capsules, Tablets, Powder) Store at controlled room temperature (20 C to 25 C), protected from moisture and light. Keep bottle tightly closed in original container.
Reconstituted Suspension Refrigeration (2 C to 8 C) is recommended. Discard unused suspension after 14 days (refrigerated) or 7 days (room temperature). Do not freeze.

Disposal Instructions

Unused or expired Flamox should be returned via a community drug take-back program. If no program is available, official guidelines require disposal in the household trash by mixing with an undesirable substance (e.g., used coffee grounds) and sealing the mixture. Do not flush this medicine down the toilet or pour it down a sink.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Flamox found in:

A-Z Index: